Concepedia

Author

Ma Shenglin

Wenzhou Medical University

Also Known As

M. A. Shenglin, M. Shenglin, Ma Shenglin

17

Publications

65

Citations

4

H-Index

12

Concepts

All Affiliations

Wenzhou Medical University
MS

About

Ma Shenglin is an author at Wenzhou Medical University specializing in tumor biology, cancer therapeutics, and surgical oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

26

2

Pathology

1

1

26

3

Surgical Oncology

1

1

26

4

Cancer Cell Biology

1

1

26

5

Cancer Therapeutics

1

1

26

Ma Shenglin

×

3

Publications

48

Citations

3

H-Index

YearCitations

Efficacy, tolerability, and biomarker analyses from a phase III, randomized, placebo-controlled, parallel group study of gefitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) (INFORM; C-TONG 0804).

L. Zhang, Ma Shenglin, Xianmin Song,

Journal of Clinical Oncology

2011

26

Clinical study of cisplatin hyperthermic intraperitoneal perfusion chemotherapy in combination with docetaxel, 5-flourouracil and leucovorin intravenous chemotherapy for the treatment of advanced-stage gastric carcinoma.

Zhibing Wu, Deng Qing-hua, Ma Shenglin,

PubMed

2014

11

Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study

Lucheng Zhu, Changlin Zou, Zhanchun Zhang,

BMC Cancer

2021

11

Page 1